Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14659815rdf:typepubmed:Citationlld:pubmed
pubmed-article:14659815lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:14659815lifeskim:mentionsumls-concept:C0020542lld:lifeskim
pubmed-article:14659815lifeskim:mentionsumls-concept:C0036753lld:lifeskim
pubmed-article:14659815lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:14659815pubmed:issue3lld:pubmed
pubmed-article:14659815pubmed:dateCreated2003-12-8lld:pubmed
pubmed-article:14659815pubmed:abstractTextIt has been reported that serotonin (5-HT) is involved in the development of pulmonary arterial hypertension (PAH) with pulmonary vascular remodeling. The purpose of the present study was to examine the role of a 5-HT2A receptor antagonist, sarpogrelate hydrochroride, in preventing or reversing monocrotaline (MCT)-induced PAH in rats.lld:pubmed
pubmed-article:14659815pubmed:languageenglld:pubmed
pubmed-article:14659815pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14659815pubmed:citationSubsetIMlld:pubmed
pubmed-article:14659815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14659815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14659815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14659815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14659815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14659815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14659815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14659815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14659815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14659815pubmed:statusMEDLINElld:pubmed
pubmed-article:14659815pubmed:monthDeclld:pubmed
pubmed-article:14659815pubmed:issn0008-6363lld:pubmed
pubmed-article:14659815pubmed:authorpubmed-author:TerasawaFumik...lld:pubmed
pubmed-article:14659815pubmed:authorpubmed-author:OkumuraNobuoNlld:pubmed
pubmed-article:14659815pubmed:authorpubmed-author:HongoMinoruMlld:pubmed
pubmed-article:14659815pubmed:authorpubmed-author:KinoshitaOsam...lld:pubmed
pubmed-article:14659815pubmed:authorpubmed-author:UshiyamaYoshi...lld:pubmed
pubmed-article:14659815pubmed:authorpubmed-author:YazakiYoshika...lld:pubmed
pubmed-article:14659815pubmed:authorpubmed-author:SakaiAkioAlld:pubmed
pubmed-article:14659815pubmed:authorpubmed-author:HironakaEijiElld:pubmed
pubmed-article:14659815pubmed:authorpubmed-author:MawatariEiich...lld:pubmed
pubmed-article:14659815pubmed:authorpubmed-author:YamazakiAkieAlld:pubmed
pubmed-article:14659815pubmed:issnTypePrintlld:pubmed
pubmed-article:14659815pubmed:day1lld:pubmed
pubmed-article:14659815pubmed:volume60lld:pubmed
pubmed-article:14659815pubmed:ownerNLMlld:pubmed
pubmed-article:14659815pubmed:authorsCompleteYlld:pubmed
pubmed-article:14659815pubmed:pagination692-9lld:pubmed
pubmed-article:14659815pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:14659815pubmed:meshHeadingpubmed-meshheading:14659815...lld:pubmed
pubmed-article:14659815pubmed:meshHeadingpubmed-meshheading:14659815...lld:pubmed
pubmed-article:14659815pubmed:meshHeadingpubmed-meshheading:14659815...lld:pubmed
pubmed-article:14659815pubmed:meshHeadingpubmed-meshheading:14659815...lld:pubmed
pubmed-article:14659815pubmed:meshHeadingpubmed-meshheading:14659815...lld:pubmed
pubmed-article:14659815pubmed:meshHeadingpubmed-meshheading:14659815...lld:pubmed
pubmed-article:14659815pubmed:meshHeadingpubmed-meshheading:14659815...lld:pubmed
pubmed-article:14659815pubmed:meshHeadingpubmed-meshheading:14659815...lld:pubmed
pubmed-article:14659815pubmed:meshHeadingpubmed-meshheading:14659815...lld:pubmed
pubmed-article:14659815pubmed:meshHeadingpubmed-meshheading:14659815...lld:pubmed
pubmed-article:14659815pubmed:meshHeadingpubmed-meshheading:14659815...lld:pubmed
pubmed-article:14659815pubmed:meshHeadingpubmed-meshheading:14659815...lld:pubmed
pubmed-article:14659815pubmed:meshHeadingpubmed-meshheading:14659815...lld:pubmed
pubmed-article:14659815pubmed:meshHeadingpubmed-meshheading:14659815...lld:pubmed
pubmed-article:14659815pubmed:meshHeadingpubmed-meshheading:14659815...lld:pubmed
pubmed-article:14659815pubmed:year2003lld:pubmed
pubmed-article:14659815pubmed:articleTitleSerotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats.lld:pubmed
pubmed-article:14659815pubmed:affiliationDepartment of Laboratory Medicine, Shinshu University School of Medicine, Matsumoto, Japan.lld:pubmed
pubmed-article:14659815pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14659815pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14659815lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14659815lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14659815lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14659815lld:pubmed